Publications by authors named "Milos D Miljkovic"

Claim this Profile
D
Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis.
Nizar Chahin, Gregory Sahagian, Marc H Feinberg, C Andrew Stewart, Christopher M Jewell

Ann Clin Transl Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cues.
C Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, Yi Zhang, Hafsa Kamboh, Milos D Miljkovic

Nat Biomed Eng· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies.
Max J Gordon, Sigrid Dubois, Milos D Miljkovic, Samuel Ng, Bonita Bryant

Blood Neoplasia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In response to: "Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee" by Greco et al.
James F Howard, Susan M Manzi, Milos D Miljkovic, Tuan Vu, Tahseen Mozaffar

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering CAR-T therapies for autoimmune disease and beyond.
Emily P English, Rachel N Swingler, Simran Patwa, Mehmet Tosun, James F Howard

Sci Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
Max J Gordon, Sigrid Dubois, Bonita Bryant, Samuel Ng, Kevin Conlon, Milos D Miljkovic

Leuk Lymphoma· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Drug Price and Novelty in Mechanism of Action.
Miloš D Miljkovic, Jordan Tuia, Timothée Olivier, Alyson Haslam, Vinay Prasad

JAMA Netw Open· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.
Volkan Granit, Michael Benatar, Metin Kurtoglu, Miloš D Miljković, Nizar Chahin

Lancet Neurol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paxlovid: A Regulatory Gamble.
Miloš D Miljković, Vinay Prasad

Am J Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming bioengineering with unbiased teams and tools.
Christopher M Jewell, Miloš D Miljković, Robert S Oakes

Nat Rev Bioeng· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-15 augments NK cell-mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies.
Milos D Miljkovic, Sigrid P Dubois, Jürgen R Müller, Bonita Bryant, Elaine Ma

Blood Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020.
Miloš D Miljkovic, Jordan E Tuia, Timothée Olivier, Alyson Haslam, Vinay Prasad

JAMA Intern Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.
Anusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, Shyh-Ming Yang, Philip Homan, Milos D Miljkovic

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL.
Milos D Miljkovic, Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Nicole Lucas

Blood Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry.
Marc Sorigue, Eloi Cañamero, Milos D Miljkovic

Blood Rev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies.
Sigrid P Dubois, Milos D Miljkovic, Thomas A Fleisher, Stefania Pittaluga, Jennifer Hsu-Albert

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell lymphomas: A 5-body problem.
Milos D Miljkovic

Semin Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15 in the Combination Immunotherapy of Cancer.
Thomas A Waldmann, Sigrid Dubois, Milos D Miljkovic, Kevin C Conlon

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018.
Patrick C DeMartino, Miloš D Miljkovic, Vinay Prasad

JAMA Intern Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia.
Anusara Daenthanasanmak, Yuquan Lin, Meili Zhang, Bonita R Bryant, Michael N Petrus, Milos D Miljkovic

Transl Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
Marc Sorigue, Laura Magnano, Milos D Miljkovic, Javier Nieto-Moragas, Mireia Santos-Gomez

Cytometry B Clin Cytom· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.
Kevin C Conlon, Claude Sportes, Martin W Brechbiel, Daniel H Fowler, Ronald Gress, Milos D Miljkovic

Cancer Biother Radiopharm· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer.
Thomas A Waldmann, Milos D Miljkovic, Kevin C Conlon

J Exp Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists.
Marc Sorigue, Milos D Miljkovic

J Oncol Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade.
Daniel A Rauch, Kevin C Conlon, Murali Janakiram, Jonathan E Brammer, John C Harding, Milos D Miljkovic

Blood· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis